Beta-adrenergic blockers. Choosing among them.
The six currently available beta-adrenergic blocking agents have significant and clinically important differences in their potency, selectivity, partial agonist effect, lipid solubility, and cost. These differences account for many of the observed variations in drug action and dosage scheduling as well as for some of the side effects. Careful choices within this group may lead to more effective treatment.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D001262:Atenolol / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy; D006801:Humans; D007700:Kinetics; D008790:Metoprolol / Q000378:metabolism; D009248:Nadolol; D010869:Pindolol / Q000378:metabolism; D011412:Propanolamines / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D013999:Timolol / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D001262:Atenolol; D013999:Timolol; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol